I think what I've really wanted to do since I was a teenager was work on HIV and TB, and conditions that affected people who ...

When volunteers launched Pittsburgh Aids Task Force in 1985, they didn’t expect the organization would be operating 40 years later.

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

Five years ago, in the heart of Kibra, Nairobi, Boniface Mukuha, 28, met Medrine Kemunto, 28, in a cybercafé—an unassuming setting for what would become an extraordinary love story. She had just ...

In 2023, after a brief hiatus, tuberculosis regained from COVID its status as the world’s deadliest infectious disease—a ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...

The Kenya Medical Supplies Authority (KEMSA) on Friday released antiretroviral drugs (ARVs) to reach over 1 million Kenyans.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.